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AbstrACt
Introduction Many studies have explored the impact 
of lifestyle interventions on depression. However, little is 
known about the effectiveness of complex multiple-risk 
lifestyle interventions in reducing symptoms of depression. 
Our objective is to assess the effectiveness of complex 
multiple-risk lifestyle interventions in reducing depressive 
symptoms in the adult population by the acquisition of at 
least two healthy habits—healthy diet, physical activity 
and/or smoking cessation. For such purpose, a systematic 
review and meta-analysis of randomised controlled trials 
will be conducted.
Method and analysis MEDLINE (through Ovid and 
PubMed), Scopus, Cochrane Central Register of Controlled 
Trials, Web of Science, PsycINFO, OpenGrey Register 
(System for Information on Grey Literature in Europe) 
and the International Clinical Trials Registry Platform 
will be searched for relevant articles. Additionally, a 
supplementary manual search will be performed using 
lists of references, references to expert authors and 
other systematic reviews and/or meta-analyses. Study 
selection, data extraction (target habits, country, target 
populations, conditions and statistical data to name a 
few) and assessment of the risk of bias will be performed 
separately by two independent researchers. The primary 
outcome measure will be the reduction of depression 
symptoms, as measured by validated instruments. We will 
calculate pooled standardised mean differences and 95% 
CIs using random-effect models. Heterogeneity, sensitivity 
and publication bias will be assessed, and sub-group 
analysis will be performed. Heterogeneity will be explored 
by random-effects meta-regression analysis.
Ethics and dissemination Ethical approval is not 
required for this study. The results of this systematic 
review and meta-analysis will be presented in relevant 
conferences and published in a peer-review journal. The 
findings of this study could have important clinical and 
scientific implications for the improvement of symptoms of 
depression.
PrOsPErO registration number CRD42018100253; 
Pre-results.
IntrOduCtIOn  
Depression affects more than 300 million 
people worldwide and is the first global cause 
of disability.1 Some studies have shown that 
pharmacological and psychological treat-
ments reduce disease burden by less than 
30%.2 Many randomised controlled trials 
(RCTs) and systematic reviews have been 
conducted to assess the efficacy of different 
interventions in the prevention of depression, 
strengths and limitations of this study
 ► This is the first systematic review and meta-analysis 
to assess the effectiveness of complex multiple-risk 
lifestyle interventions in reducing depressive symp-
toms by the promotion of healthy habits in the adult 
population.
 ► This study will be conducted in accordance with 
Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses statement for reporting system-
atic reviews and meta-analyses.
 ► The effect size, robustness and quality of evidence 
of the studies included in this meta-analysis will 
help to determine whether symptoms of depression 
can be improved by complex multiple-risk lifestyle 
interventions based on the acquisition of healthy 
habits.
 ► This study will have the limitations inherent to all 
systematic reviews and meta-analyses (ie, missing 
outcome data, methodological flaws and risk of bias 
of the studies included).
 ► Bias, heterogeneity and the small sample of studies 
could limit the interpretation of results.
 o
n
 M
ay 28, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026842 on 15 March 2019. Downloaded from 
2 Gómez-Gómez I, et al. BMJ Open 2019;9:e026842. doi:10.1136/bmjopen-2018-026842
Open access 
the reduction of new episodes3–5 or the improvement of 
depressive symptoms.6 7 
Recent compelling evidence suggests that depression 
has a significant lifestyle-driven component.8 It is increas-
ingly accepted that poor sleep, dietary habits, smoking 
and sedentary habits are important modifiable risk 
factors for depressive disorders.9–12 Nowadays, the most 
prevalent lifestyle risk factors in many countries include 
tobacco use, physical inactivity and unhealthy diet.13–16
In most studies, lifestyle interventions for the preven-
tion of depression are only focused on a specific healthy 
habit.17–26 Nevertheless, unhealthy lifestyle factors tend to 
co-occur; it has been reported that 31%–40% of the popu-
lation has at least two risk factors.14 27 Evidence suggests 
that complex multiple-risk lifestyle interventions provide 
greater health benefits, reduce costs and optimise the 
promotion of healthy habits.28
According to our search, only three systematic reviews 
and meta-analyses have explored the effect of multifac-
torial lifestyle interventions on symptoms of depression. 
One of these studies29 was focused on both single and 
multifactorial lifestyle interventions promoting healthy 
diet and physical activity in high-risk or type-2 diabetes 
patients. The other study30 only evaluated a lifestyle/
psychological intervention versus a multi-component 
intervention based on a combination of lifestyle and 
psychological interventions in patients with chronic 
obstructive pulmonary disease. The third study31 assessed 
the effects of dietary interventions and complex multi-
ple-risk lifestyle interventions. Thus, most studies were 
focused on dietary and physical activity interventions 
addressed at a specific population. Some complex inter-
ventions combined a psychological intervention with an 
intervention on a specific lifestyle habit.30
To the best of our knowledge, no systematic review 
or meta-analysis has been performed so far to explore 
the effectiveness of complex multiple-risk lifestyle inter-
ventions in reducing depressive symptoms in the adult 
population.
A systematic review and meta-analysis of RCTs will be 
conducted. The objective is to assess the effectiveness of 
complex multiple-risk lifestyle interventions in reducing 
depressive symptoms in the adult population by the 
promotion of at least two healthy habits (healthy diet, 
physical activity and/or smoking cessation). The research 
question of this study will be: Are complex multiple-risk life-
style interventions effective in improving symptoms of depression 
in the adult population? This study will help to understand if 
symptoms of depression improve with the implementation 
of complex multiple-risk lifestyle interventions promoting 
the acquisition of healthy habits. The expected results will 
have multiple implications, since complex multiple-risk 
lifestyle interventions prevent other non-communicable 
diseases,32 reduce medical costs33 and improve self-effi-
cacy in patients.34 Furthermore, complex multiple-risk 
lifestyle interventions respond accurately to clustering 
of unhealthy lifestyle factors14 27 and can easily be imple-
mented in different settings.26 32 35 36
MEthOds And AnAlysIs
This protocol was designed in accordance with the 
2015 Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses Protocols.37 The protocol was regis-
tered with the International Register of Systematic 
Reviews (http://www. crd. york. ac. uk/ PROSPERO) on 18 
September 2018.
Eligibility criteria
The rationale for the inclusion and exclusion criteria 
(using PICOS acronym38) was to select RCTs (S) assessing 
the effectiveness of complex multiple-risk lifestyle inter-
ventions (I)—as compared with usual care (ie, staying in 
the waiting list, no intervention or joining an attention 
control group [C])—in promoting healthy behaviours to 
reduce symptoms of depression (O) in the adult popu-
lation (P). Table 1 presents the inclusion and exclusion 
criteria.
study design
Only randomised control and clinical trials will be 
included, since according to the ‘hierarchy of evidence’, 
these designs provide the best evidence for health-
care interventions.39 In relation to cluster randomised 
control/clinical trials, we will only include those with 
at least two clusters per intervention and per control 
group, with analysis of effectiveness was adjusted for the 
clustering effect. Observational studies, non-RCTs and 
before–after studies will be excluded. Concerning more 
than two-arm interventions, we will only include the arms 
that meet our inclusion criteria.
Participants, setting, time frame and language
We will consider the entire adult population, with no 
restrictions in terms of disease or health status (ie, healthy 
people and patients with chronic diseases, among others). 
Participants must be 18 years or older. No other sociode-
mographic restrictions will be imposed. All settings will 
be considered and no time frame or language restrictions 
will be applied to the literature search. In purely preven-
tive intervention studies, baseline depression must have 
been discarded using a standardised diagnostic tool or 
a threshold in a validated scale. In relation to inclusion 
criteria, as it is unlikely that baseline depression was 
assessed in RCTs to exclude depressive patients, it will only 
be required that baseline symptoms of depression were 
assessed. Baseline depression scores will be considered to 
clearly distinguish between different types of prevention 
interventions. Studies which target population includes 
only patients meeting the diagnostic criteria for clinical 
depression will be excluded, as these are considered treat-
ment rather than preventive interventions.
type of intervention
We will include complex multiple-risk lifestyle interven-
tions, defined as interventions or programmes promoting 
the acquisition of at least two of the following healthy 
habits: healthy diet, physical activity and/or smoking 
cessation. Quantitative and qualitative approaches will be 
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used for evaluating healthy diet interventions. Healthy 
diets include the Mediterranean diet,40 41 the Dietary 
Approaches to Stop Hypertension diet,42 43 the Japanese 
diet,44 45 any diet with a target of five pieces of fruit and vege-
tables per day46 and any diet where saturated fats account 
for less than 10% of the total daily energy intake.47 48 In 
relation to physical activity, we will consider interven-
tions that involve at least 150 or 75 minutes of moderate 
or vigorous aerobic exercise, respectively, per week, or an 
equivalent time where moderate and vigorous activities 
are combined.49 Smoking cessation interventions will be 
required to include a self-reported and/or biochemi-
cally validated outcome of continuous abstinence, and/
or prolonged abstinence, and/or point prevalence. In 
addition, we will include studies where treatment effect 
size is expressed as the absolute percentage difference 
between abstinence and smoking or the magnitude of 
the difference between active and control interventions. 
For continuous abstinence, any smoking between the 
quit day and the end of the follow-up will be considered a 
failure. Failure of prolonged abstinence will be defined as 
smoking seven consecutive days or at least once a week for 
two consecutive weeks after the quit day. Failure of point 
prevalence will be defined as any smoking 7 days prior to 
the follow-up.50 Studies with pharmacological therapy for 
smoking cessation will be excluded.
Comparators
Comparator groups will include a usual care group, a 
waiting list group, a non-intervention group (patients 
undergo the same assessments as the treatment group, 
but were not engaged in any intervention) and attention 
controls (active control or placebo).
Outcome
We will only include RCTs which primary or secondary 
outcome measure is variance in symptoms of depression. 
Outcomes must have been measured using validated 
rating scales for depression. If more than one scale was 
used to assess depression, only the results of the scale 
with the best psychometric properties for the setting and 
country will be used. If this information is not provided by 
the authors, a literature search will be conducted to find 
it out. When several scales have been used, the parame-
ters used to select the best scale are: a higher Youden’s 
J statistic (J=Sensitivity+Specificity−1), Cronbach’s alpha 
and intraclass correlation coefficient (test–retest); and 
sensitivity to change over time (Yes/no/not available). 
Studies, where effects on depression and other mood 
disorders (eg, anxiety) are not provided separately, will 
be excluded.
Outcomes will have been addressed during the post-in-
tervention period and the last follow-up visit of the study. 
When available, we will consider the average of all the 
follow-up visits.
Information resources and search strategy
A literature search of the following electronic databases 
will be performed: MEDLINE (via Ovid and PubMed), 
Scopus, Cochrane Central Register of Controlled Trial, 
Table 1 Inclusion and exclusion criteria
Criteria Inclusion criteria Exclusion criteria
Population Adults over 18 years of age. Studies which target population are patients meeting the 
diagnostic criteria for clinical depression.
Intervention Complex multiple-risk lifestyle interventions addressing 
at least two of the following factors: healthy diet, physical 
activity and smoking cessation*.
Any other intervention that was not a complex multiple-
risk lifestyle intervention.
Comparator Usual care, waiting list, non- intervention or attention 
controls (active control or placebo)
Any other type of comparison or intervention.
Outcome Reduction of symptoms of depression. Interventions which effects on depression or other 
diseases are not reported separately (or which effective 
measures are not provided separately).
Study design Randomised controlled trials, randomised clinical trials or 
clinical trials
Prospective cohort, retrospective cohort, cross-sectional, 
case-control, systematic reviews and meta-analysis, 
protocols, clinical case, editors’ letters, qualitative 
studies and observational studies
Language All languages None
Setting All settings None
*Interventions or programmes addressing at least two of the following factors: healthy diet, physical activity and/or smoking 
cessation. Healthy diet: Mediterranean diet, Dietary Approaches to Stop Hypertension diet, Japanese diet, any diet with a goal of five 
pieces of fruit and vegetables per day and any diet where saturated fats account for less than 10% of the total daily energy intake. 
Physical activity: At least 150 minutes of moderate-intensity aerobic physical activity throughout the week, or at least 75 minutes of 
vigorous-intensity aerobic physical activity throughout the week, or an equivalent combination of moderate-intensity and vigorous-
intensity activities. Smoking cessation: Any smoking cessation intervention with a self-reported and/or biochemically validated 
abstinence outcome measure of continuous abstinence, and/or prolonged abstinence, and/or point prevalence; and studies where 
treatment effect size is reported based either on the absolute percentage difference between abstinent subjects and smokers or the 
magnitude of the difference between active and control conditions.
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PsycINFO, Web of Science, OpenGrey Repository (System 
for Information on Grey Literature in Europe) and the 
International Clinical Trials Registry Platform. Addition-
ally, an online supplementary file manual search will be 
performed using lists of references, references to expert 
authors and other systematic reviews and/or meta-anal-
yses of multiple or single lifestyle interventions focused on 
healthy diet, physical activity or smoking cessation. The 
search strategy will involve the use of a set of terms selected 
from the relevant literature. We will use Medical Subject 
Headings and text words related to healthy diet, physical 
activity, smoking cessation and depression. The search will 
be first performed in MEDLINE and will subsequently be 
adapted to the other relevant databases. The time frame 
of the search will extend until the review is completed. 
The online supplementary file shows Medline’s search 
strategy using the PICOS format in PubMed. No limits will 
be imposed on study language or publication date.
study selection
The study selection process will be performed in three 
phases: first, duplicated records will be eliminated; then a 
selection of titles and abstracts will be conducted; finally, 
only selected records will be read full-text. The whole 
process will be completed twice by two independent 
researchers. Discrepancies will be solved by consensus 
between the two reviewers; if the consensus is not reached, 
a third reviewer will make the final decision. The level of 
agreement between researches will be calculated using 
Kappa index.51
data extraction
An evidence table will be generated to display the most 
relevant characteristics of each study. If several records 
of the same study are found, they will be computed as a 
single study, and data extraction will be made all at once 
using information from all the records. Paper screening 
and selection, and data extraction will be performed by 
two independent reviewers twice. Discrepancies will be 
solved by a third reviewer. In case of missing data, authors 
will be contacted. The following qualitative data will be 
collected: authors, year of publication, country, primary 
outcome, target population, target habits (healthy diet, 
physical activity and/or smoking cessation), character-
istics of the complex intervention (total duration of the 
intervention, framework and session format), conditions, 
sample size (control/intervention), deliverer, outcome 
(measuring instrument), adherence to healthy habits at 
the end of the intervention and setting and duration of 
the follow-up.
Regarding quantitative data, we will extract means and 
SD, when available, to calculate the standardised mean 
difference (SMD). If some RCTs report other formats, 
Comprehensive Meta-analysis (CMA) will be used to 
obtain the equivalent SMD.
risk of bias
The internal validity of the selected studies will be assessed 
using the Cochrane Collaboration’s tool for assessing 
risk of bias.52 This tool assesses six general dimensions 
or criteria: selection bias (random sequence genera-
tion and allocation concealment), performance bias 
(blinding of participants and trial personnel), detection 
bias (blinding of evaluators of outcome assessment), attri-
tion bias (missing outcome data), reporting bias (selec-
tive reporting) and other biases (other sources of bias). 
In all items, zero points are assigned for low risk of bias, 
one point for unclear risk and two points for high risk. 
The risk of bias will be assessed twice by two independent 
reviewers. Discrepancies will be solved by a third reviewer. 
The level of agreement between researches will be calcu-
lated using the intraclass correlation coefficient.51 If addi-
tional information is required, authors will be contacted.
Assessment of publication bias
Publication bias will be assessed by a funnel plot. Duval and 
Tweedie’s trim and fill procedure53 will be used to impute 
missing data for the analysis. If the number of studies 
is equal or greater than 10, Begg and Mazumdar rank 
correlation54 and Egger’s test55 will also be performed.
statistical analysis
Two independent reviewers will insert quantitative data 
from each study twice into an Excel sheet. If there are 
missing data that hinder effect size calculation, the 
authors will be contacted. If no response is received, the 
study will be excluded. We will use CMA to convert data 
into the desired format. Quantitative data will be anal-
ysed using CMA V.3 and STATA V.14. Effects size will 
be calculated using SMD and 95% CI. A negative SMD 
will be interpreted as a greater reduction of depressive 
symptoms in the intervention group. Cohen’s interpre-
tation will be used—that is, 0.20, 0.50 and 0.80 as small, 
medium and large effect size, respectively.56 We selected 
a random-effects model for our meta-analysis, under the 
assumption that the RCTs to be included in our study will 
have been performed in heterogeneous populations that 
may differ from each other.
Heterogeneity will be assessed using forest plots, Q 
statistics, p values and I2 index values and their 95% CIs. 
I2 index values will be expressed as percentages and inter-
preted as follows: unimportant heterogeneity (0%–40%), 
moderate heterogeneity (30%–60%), substantial hetero-
geneity (50%–90%) and considerable heterogeneity 
(75%–100%).38
Sensitivity will be assessed during the first and last 
follow-up visit using fixed-effects model and Hedges’ g. 
Some studies will be excluded from analysis (eg, studies 
with the highest risk of bias or causing the greatest 
increase in heterogeneity).
Sub-group analysis will be performed to explore hetero-
geneity across studies. When available, the following data 
will be collected: year of publication, country, primary 
outcome, target population, target habits (healthy diet 
and physical activity; healthy diet and smoking cessation; 
physical activity, smoking cessation and healthy diet; 
and physical activity and smoking cessation), severity of 
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depressive symptoms at baseline, population age range, 
comparator (usual care, waiting list, non-intervention 
and attention controls), sample size, setting (ie, hospital, 
community hubs, school and workplace), characteristics 
of the complex intervention (total duration of the inter-
vention, framework and session format), follow-up (short-
term vs long- term), deliverer, and risk of bias.
Random-effects meta-regression will be used to iden-
tify differences in effect sizes in relation to risk of bias or 
time. Normality of distribution will be previously assessed 
by the Skewness and Kurtosis normality test.57 When 
appropriate, quantitative variables will be transformed 
to improve approximation to normality. Covariables with 
p values less than 0.15, which were not previously removed 
from the model due to collinearity, will be included in 
meta-regression models. CIs and standard errors will 
be calculated by the Knapp and Hartung method.58 We 
will also use Higgins and Thompson permutation test 
to calculate p values, taking multiplicity adjustment into 
account.59 We will use a plot of standardised shrunken 
residuals to test goodness of fit in meta-regression models.
Quality of evidence
Quality of evidence will be assessed using Grading of 
Recommendations Assessment, Development and Evalua-
tion (GRADE) system. GRADE system helps to determine 
if the estimated effect size is reliable or not as defined 
according to four categories: high, moderate, low and 
very low.60
Patient and public involvement
No patients or public involved.
EthICs And dIssEMInAtIOn
This systematic review and meta-analysis study will be 
published in a peer-reviewed journal. Results will be 
presented in relevant international conferences. Due to 
the characteristics of this study, no ethical approval is 
required.
dIsCussIOn
To the best of our knowledge, this will be the first system-
atic review and meta-analysis to assess the effectiveness of 
complex multiple-risk lifestyle interventions (healthy diet, 
physical activity and/or smoking cessation) in reducing 
depressive symptoms in the adult population. In this study, 
we will summarise and evaluate the quality of the most 
relevant studies. Finally, we will provide an overview of the 
current body of knowledge on complex multiple-risk life-
style interventions for reducing symptoms of depression. 
A meta-analysis will be performed and statistical integra-
tion of results will be used to compute common effect size 
and significance. The effect size, robustness and quality of 
evidence obtained in this meta-analysis will help to deter-
mine whether symptoms of depression can be reduced 
by complex multiple-risk lifestyle interventions based on 
the acquisition of healthy habits. The implication of the 
results obtained in this study is that complex multiple-risk 
lifestyle interventions could be routinely implemented in 
all patients at risk for depression in a variety of settings 
(ie, primary care centres, workplace, to name a few) and 
incorporated into treatment and prevention guidelines.
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